Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISANKIZUMAB-RZAA vs RISPERDAL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISANKIZUMAB-RZAA vs RISPERDAL: Safety Overview

Metric RISANKIZUMAB-RZAA RISPERDAL
Total FAERS Reports 65,422 530
Deaths Reported 2,269 53
Death Rate 3.5% 10.0%
Hospitalizations 14,095 235
Average Patient Age 56.5 yrs 44.7 yrs
% Female Patients 57.1% N/A
Marketing Status Prescription N/A